title: The incidence of hyperglycemia in patients treated with olanzapine.
authors.forename: Fuminari
authors.initials: F
authors.lastname: Misawa
authors.forename: Shingo
authors.initials: S
authors.lastname: Miyaji
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Fuji
authors.forename: Ryoji
authors.initials: R
authors.lastname: Miyata
authors.forename: Keiko
authors.initials: K
authors.lastname: Obi
authors.forename: Fumio
authors.initials: F
authors.lastname: Koshiishi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Shimada
authors.forename: Masamichi
authors.initials: M
authors.lastname: Fukuda
authors.forename: Takanori
authors.initials: T
authors.lastname: Koizumi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced* / Q000175:diagnosis / Q000208:ethnology*; D015994:Incidence; D007564:Japan; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine